News

Respreeza, a highly purified Alpha-1 protein derived from human plasma, is the only Alpha-1 proteinase inhibitor that has been proven in a prospective double blind, placebo controlled trial

TAPROS is the Prostaglandin F2a Analogue co-developed by Santen and Asahi Glass Co., Ltd. (Headquarters: Chiyoda-ku, Tokyo) for the reduction of intraocular pressure (IOP) in glaucoma and ocular

An additional clinical trial site has been added by the company in the UK to ease travel burden for affected individuals living in the European Union (EU). FOP

The deal provides Shire with access to Sanquin’s manufacturing technology and allowing the Irish firm to source additional manufacturers to meet the growing demand for Cinryze. Shire CEO

The product, which is the generic version of Pfizer’s Zosyn injection, is a combination of penicillin-class antibacterial and beta-lactamase inhibitor. According to IMS Health, Piperacillin and Tazobactam for

Currently underway in multiple sites in Canada, the US and Asia, the trial is designed to evaluate TKM-PLK1’s safety and efficacy in treating patients with HCC. In the

The grant will allow the company to progress OCD155 through pre-clinical development towards clinical trials and to further unravel the mechanism-of-action, which will be done in a Dutch-Danish-German-Swiss

Around 54 male patients will be enrolled in the trial, which is designed to evaluate the pharmacokinetics (PK), efficacy, and safety of rVIIa-FP in these patients who have

If etelcalcetide gets approval, it will be the first calcimimetic agent that can be administered intravenously at the end of the dialysis session. Etelcalcetide is a new calcimimetic